speb/financial-data huggingface dataset:
IBIO balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 1200000.00
IBIO balance_sheet (annual, 2025-06-30) — Current Deferred Revenue: 1200000.00
IBIO balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 1200000.00
IBIO balance_sheet (annual, 2025-06-30) — Current Liabilities: 6106000.00
IBIO balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 6106000.00
IBIO cash_flow (annual, 2025-06-30) — Depreciation: 1106000.00
IBIO cash_flow (quarterly, 2025-06-30) — Depreciation: 280000.00
IBIO cash_flow (annual, 2025-06-30) — Depreciation Amortization Depletion: 1126000.00
IBIO cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 285000.00
IBIO cash_flow (annual, 2025-06-30) — Depreciation And Amortization: 1126000.00
IBIO cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 285000.00
IBIO income_statement (annual, 2025-06-30) — Diluted Average Shares: 10499000.00
IBIO income_statement (annual, 2025-06-30) — Diluted EPS: -1.75
IBIO income_statement (annual, 2025-06-30) — Diluted NI Availto Com Stockholders: -18377000.00
IBIO income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -5163000.00
IBIO income_statement (annual, 2025-06-30) — EBIT: -18165000.00
IBIO income_statement (quarterly, 2025-06-30) — EBIT: -5119000.00
IBIO income_statement (annual, 2025-06-30) — EBITDA: -17039000.00
IBIO income_statement (quarterly, 2025-06-30) — EBITDA: -4834000.00
IBIO cash_flow (annual, 2025-06-30) — End Cash Position: 8792000.00
IBIO cash_flow (quarterly, 2025-06-30) — End Cash Position: 8792000.00
IBIO cash_flow (annual, 2025-06-30) — Financing Cash Flow: 8929000.00
IBIO cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 8180000.00
IBIO cash_flow (annual, 2025-06-30) — Free Cash Flow: -15320000.00
IBIO cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -4616000.00
IBIO cash_flow (annual, 2025-06-30) — Gain Loss On Sale Of PPE: 0.00
IBIO cash_flow (quarterly, 2025-06-30) — Gain Loss On Sale Of PPE: 0.00
IBIO income_statement (annual, 2025-06-30) — Gain On Sale Of Ppe: 0.00
IBIO income_statement (quarterly, 2025-06-30) — Gain On Sale Of Ppe: 0.00
IBIO income_statement (annual, 2025-06-30) — General And Administrative Expense: 10690000.00
IBIO income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 2174000.00
IBIO balance_sheet (annual, 2025-06-30) — Goodwill And Other Intangible Assets: 6848000.00
IBIO balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 6848000.00
IBIO balance_sheet (annual, 2025-06-30) — Gross PPE: 7523000.00
IBIO balance_sheet (quarterly, 2025-06-30) — Gross PPE: 7523000.00
IBIO income_statement (annual, 2025-06-30) — Interest Expense: 212000.00
IBIO income_statement (quarterly, 2025-06-30) — Interest Expense: 44000.00
IBIO income_statement (annual, 2025-06-30) — Interest Expense Non Operating: 212000.00
IBIO income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 44000.00
IBIO income_statement (annual, 2025-06-30) — Interest Income: 437000.00
IBIO income_statement (quarterly, 2025-06-30) — Interest Income: 79000.00
IBIO income_statement (annual, 2025-06-30) — Interest Income Non Operating: 437000.00
IBIO income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 79000.00
IBIO cash_flow (annual, 2025-06-30) — Interest Paid Supplemental Data: 212000.00
IBIO cash_flow (quarterly, 2025-06-30) — Interest Paid Supplemental Data: 44000.00
IBIO cash_flow (annual, 2025-06-30) — Interest Received Cfi: 758000.00
IBIO cash_flow (quarterly, 2025-06-30) — Interest Received Cfi: 46000.00
IBIO balance_sheet (annual, 2025-06-30) — Invested Capital: 15646000.00
IBIO balance_sheet (quarterly, 2025-06-30) — Invested Capital: 15646000.00
IBIO cash_flow (annual, 2025-06-30) — Investing Cash Flow: 742000.00
IBIO cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: 45000.00
IBIO cash_flow (annual, 2025-06-30) — Issuance Of Capital Stock: 3541000.00
IBIO cash_flow (quarterly, 2025-06-30) — Issuance Of Capital Stock: 2410000.00
IBIO cash_flow (annual, 2025-06-30) — Issuance Of Debt: 0.00
IBIO cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: 0.00
IBIO balance_sheet (annual, 2025-06-30) — Long Term Capital Lease Obligation: 2199000.00
IBIO balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 2199000.00
IBIO balance_sheet (annual, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 2199000.00
IBIO balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 2199000.00
IBIO cash_flow (annual, 2025-06-30) — Long Term Debt Issuance: 0.00
IBIO cash_flow (quarterly, 2025-06-30) — Long Term Debt Issuance: 0.00
IBIO cash_flow (annual, 2025-06-30) — Long Term Debt Payments: -695000.00
IBIO cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -183000.00
IBIO balance_sheet (annual, 2025-06-30) — Machinery Furniture Equipment: 3963000.00
IBIO balance_sheet (quarterly, 2025-06-30) — Machinery Furniture Equipment: 3963000.00
IBIO cash_flow (annual, 2025-06-30) — Net Common Stock Issuance: 3541000.00
IBIO cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: 2410000.00
IBIO income_statement (annual, 2025-06-30) — Net Income: -18377000.00
IBIO income_statement (quarterly, 2025-06-30) — Net Income: -5163000.00
IBIO income_statement (annual, 2025-06-30) — Net Income Common Stockholders: -18377000.00
IBIO income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -5163000.00
IBIO income_statement (annual, 2025-06-30) — Net Income Continuous Operations: -18377000.00
IBIO income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -5163000.00
IBIO income_statement (annual, 2025-06-30) — Net Income Discontinuous Operations: 0.00
IBIO income_statement (quarterly, 2025-06-30) — Net Income Discontinuous Operations: 0.00
IBIO income_statement (annual, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -18377000.00
IBIO income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -5163000.00
IBIO income_statement (annual, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -18377000.00
IBIO income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -5163000.00
IBIO cash_flow (annual, 2025-06-30) — Net Income From Continuing Operations: -18377000.00
IBIO cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -5163000.00
IBIO income_statement (annual, 2025-06-30) — Net Income Including Noncontrolling Interests: -18377000.00
IBIO income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -5163000.00
IBIO cash_flow (annual, 2025-06-30) — Net Intangibles Purchase And Sale: 0.00
IBIO cash_flow (quarterly, 2025-06-30) — Net Intangibles Purchase And Sale: 0.00
IBIO income_statement (annual, 2025-06-30) — Net Interest Income: 225000.00
IBIO income_statement (quarterly, 2025-06-30) — Net Interest Income: 35000.00
IBIO cash_flow (annual, 2025-06-30) — Net Issuance Payments Of Debt: -695000.00
IBIO cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: -183000.00
IBIO cash_flow (annual, 2025-06-30) — Net Long Term Debt Issuance: -695000.00
IBIO cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: -183000.00
IBIO income_statement (annual, 2025-06-30) — Net Non Operating Interest Income Expense: 225000.00
IBIO income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: 35000.00
IBIO cash_flow (annual, 2025-06-30) — Net Other Financing Charges: -294000.00
IBIO balance_sheet (annual, 2025-06-30) — Net PPE: 5282000.00
IBIO balance_sheet (quarterly, 2025-06-30) — Net PPE: 5282000.00
IBIO cash_flow (annual, 2025-06-30) — Net PPE Purchase And Sale: -16000.00
IBIO cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -1000.00
IBIO cash_flow (annual, 2025-06-30) — Net Short Term Debt Issuance: 0.00
IBIO balance_sheet (annual, 2025-06-30) — Net Tangible Assets: 8032000.00
IBIO balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 8032000.00
IBIO balance_sheet (annual, 2025-06-30) — Non Current Note Receivables: 1098000.00
IBIO balance_sheet (quarterly, 2025-06-30) — Non Current Note Receivables: 1098000.00
IBIO balance_sheet (annual, 2025-06-30) — Non Current Prepaid Assets: 26000.00
IBIO balance_sheet (quarterly, 2025-06-30) — Non Current Prepaid Assets: 26000.00
IBIO income_statement (annual, 2025-06-30) — Normalized EBITDA: -17039000.00
IBIO income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -4834000.00
IBIO income_statement (annual, 2025-06-30) — Normalized Income: -18377000.00
IBIO income_statement (quarterly, 2025-06-30) — Normalized Income: -5163000.00
IBIO balance_sheet (annual, 2025-06-30) — Notes Receivable: 0.00
IBIO balance_sheet (quarterly, 2025-06-30) — Notes Receivable: 0.00
IBIO cash_flow (annual, 2025-06-30) — Operating Cash Flow: -15304000.00
IBIO cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -4615000.00
IBIO income_statement (annual, 2025-06-30) — Operating Income: -18602000.00
IBIO income_statement (quarterly, 2025-06-30) — Operating Income: -5198000.00
IBIO income_statement (annual, 2025-06-30) — Operating Revenue: 400000.00
IBIO income_statement (quarterly, 2025-06-30) — Operating Revenue: 200000.00
IBIO balance_sheet (annual, 2025-06-30) — Ordinary Shares Number: 19349201.00
IBIO balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 19349201.00
IBIO balance_sheet (annual, 2025-06-30) — Other Current Assets: 1034000.00
IBIO balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 1034000.00
IBIO balance_sheet (annual, 2025-06-30) — Other Current Borrowings: 766000.00
IBIO balance_sheet (quarterly, 2025-06-30) — Other Current Borrowings: 766000.00
IBIO income_statement (annual, 2025-06-30) — Other Gand A: 10690000.00
IBIO income_statement (quarterly, 2025-06-30) — Other Gand A: 2174000.00
IBIO balance_sheet (annual, 2025-06-30) — Other Intangible Assets: 6848000.00
IBIO balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 6848000.00
IBIO cash_flow (annual, 2025-06-30) — Other Non Cash Items: -62000.00
IBIO cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: -15000.00
IBIO balance_sheet (annual, 2025-06-30) — Other Non Current Assets: 210000.00
IBIO balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 210000.00
IBIO balance_sheet (annual, 2025-06-30) — Other Payable: 64000.00
IBIO balance_sheet (quarterly, 2025-06-30) — Other Payable: 64000.00
IBIO balance_sheet (annual, 2025-06-30) — Other Properties: 2865000.00
IBIO balance_sheet (quarterly, 2025-06-30) — Other Properties: 2865000.00
IBIO balance_sheet (annual, 2025-06-30) — Other Receivables: 105000.00
IBIO balance_sheet (quarterly, 2025-06-30) — Other Receivables: 105000.00
IBIO balance_sheet (annual, 2025-06-30) — Payables: 2252000.00
IBIO balance_sheet (quarterly, 2025-06-30) — Payables: 2252000.00
IBIO balance_sheet (annual, 2025-06-30) — Payables And Accrued Expenses: 2721000.00
IBIO balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 2721000.00
IBIO balance_sheet (annual, 2025-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 876000.00
IBIO balance_sheet (quarterly, 2025-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 876000.00
IBIO balance_sheet (annual, 2025-06-30) — Preferred Stock: 0.00
IBIO balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 0.00
IBIO income_statement (annual, 2025-06-30) — Pretax Income: -18377000.00
IBIO income_statement (quarterly, 2025-06-30) — Pretax Income: -5163000.00
IBIO cash_flow (annual, 2025-06-30) — Proceeds From Stock Option Exercised: 6377000.00
IBIO cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 6247000.00
IBIO balance_sheet (annual, 2025-06-30) — Properties: 0.00
IBIO balance_sheet (quarterly, 2025-06-30) — Properties: 0.00
IBIO cash_flow (annual, 2025-06-30) — Purchase Of PPE: -16000.00
IBIO cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -1000.00
IBIO balance_sheet (annual, 2025-06-30) — Receivables: 105000.00
IBIO balance_sheet (quarterly, 2025-06-30) — Receivables: 105000.00
IBIO income_statement (annual, 2025-06-30) — Reconciled Depreciation: 1126000.00
IBIO income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 285000.00
IBIO cash_flow (annual, 2025-06-30) — Repayment Of Debt: -695000.00
IBIO cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -183000.00
IBIO cash_flow (annual, 2025-06-30) — Repurchase Of Capital Stock: 0.00
IBIO cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: 0.00
IBIO income_statement (annual, 2025-06-30) — Research And Development: 8312000.00
IBIO income_statement (quarterly, 2025-06-30) — Research And Development: 3224000.00
IBIO balance_sheet (annual, 2025-06-30) — Retained Earnings: -332224000.00
IBIO balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -332224000.00
IBIO cash_flow (annual, 2025-06-30) — Sale Of Intangibles: 0.00
IBIO cash_flow (quarterly, 2025-06-30) — Sale Of Intangibles: 0.00
IBIO cash_flow (annual, 2025-06-30) — Sale Of PPE: 0.00
IBIO cash_flow (quarterly, 2025-06-30) — Sale Of PPE: 0.00
IBIO income_statement (annual, 2025-06-30) — Selling General And Administration: 10690000.00
IBIO income_statement (quarterly, 2025-06-30) — Selling General And Administration: 2174000.00
IBIO balance_sheet (annual, 2025-06-30) — Share Issued: 19349201.00
IBIO balance_sheet (quarterly, 2025-06-30) — Share Issued: 19349201.00
IBIO cash_flow (annual, 2025-06-30) — Short Term Debt Payments: 0.00
IBIO income_statement (annual, 2025-06-30) — Special Income Charges: 0.00
IBIO income_statement (quarterly, 2025-06-30) — Special Income Charges: 0.00
IBIO cash_flow (annual, 2025-06-30) — Stock Based Compensation: 1530000.00
IBIO cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 270000.00
IBIO balance_sheet (annual, 2025-06-30) — Stockholders Equity: 14880000.00
IBIO balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 14880000.00
IBIO balance_sheet (annual, 2025-06-30) — Tangible Book Value: 8032000.00
IBIO balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 8032000.00
IBIO income_statement (annual, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
IBIO income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
IBIO income_statement (annual, 2025-06-30) — Tax Rate For Calcs: 0.00
IBIO income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.00
IBIO balance_sheet (annual, 2025-06-30) — Total Assets: 23185000.00
IBIO balance_sheet (quarterly, 2025-06-30) — Total Assets: 23185000.00
IBIO balance_sheet (annual, 2025-06-30) — Total Capitalization: 14880000.00
IBIO balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 14880000.00
IBIO balance_sheet (annual, 2025-06-30) — Total Debt: 3508000.00
IBIO balance_sheet (quarterly, 2025-06-30) — Total Debt: 3508000.00
IBIO balance_sheet (annual, 2025-06-30) — Total Equity Gross Minority Interest: 14880000.00
IBIO balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 14880000.00
IBIO income_statement (annual, 2025-06-30) — Total Expenses: 19002000.00
IBIO income_statement (quarterly, 2025-06-30) — Total Expenses: 5398000.00
IBIO balance_sheet (annual, 2025-06-30) — Total Liabilities Net Minority Interest: 8305000.00
IBIO balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 8305000.00
IBIO balance_sheet (annual, 2025-06-30) — Total Non Current Assets: 13464000.00
IBIO balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 13464000.00
IBIO balance_sheet (annual, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 2199000.00
IBIO balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 2199000.00
IBIO income_statement (annual, 2025-06-30) — Total Operating Income As Reported: -18602000.00
IBIO income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -5198000.00
IBIO income_statement (annual, 2025-06-30) — Total Unusual Items: 0.00
IBIO income_statement (quarterly, 2025-06-30) — Total Unusual Items: 0.00
IBIO income_statement (annual, 2025-06-30) — Total Unusual Items Excluding Goodwill: 0.00
IBIO income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 0.00
IBIO balance_sheet (annual, 2025-06-30) — Tradeand Other Payables Non Current: 0.00
IBIO balance_sheet (quarterly, 2025-06-30) — Tradeand Other Payables Non Current: 0.00
IBIO balance_sheet (annual, 2025-06-30) — Working Capital: 3615000.00
IBIO balance_sheet (quarterly, 2025-06-30) — Working Capital: 3615000.00
IBIO income_statement (quarterly, 2025-09-30) — +Operating Expense: 6051000.00
IBIO income_statement (quarterly, 2025-09-30) — +Total Revenue: 100000.00
IBIO balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 2822000.00
IBIO balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 65000.00
IBIO balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -1679000.00
IBIO balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 393978000.00
IBIO cash_flow (quarterly, 2025-09-30) — Amortization Cash Flow: 5000.00
IBIO cash_flow (quarterly, 2025-09-30) — Amortization Of Intangibles: 5000.00
IBIO cash_flow (quarterly, 2025-09-30) — Amortization Of Securities: -9000.00
IBIO income_statement (quarterly, 2025-09-30) — Basic Average Shares: 52981000.00
IBIO income_statement (quarterly, 2025-09-30) — Basic EPS: -0.11
IBIO cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 8792000.00
IBIO balance_sheet (quarterly, 2025-09-30) — Buildings And Improvements: 695000.00
IBIO cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -32000.00
IBIO balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 2572000.00
IBIO balance_sheet (quarterly, 2025-09-30) — Capital Stock: 20000.00
IBIO balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 28111000.00
IBIO balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 49567000.00
IBIO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 46705000.00
IBIO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -21493000.00
IBIO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -5665000.00
IBIO cash_flow (quarterly, 2025-09-30) — Change In Account Payable: 495000.00
IBIO cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: -686000.00
IBIO cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: -117000.00
IBIO cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: -50000.00
IBIO cash_flow (quarterly, 2025-09-30) — Change In Payable: 495000.00
IBIO cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: -191000.00
IBIO cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: -106000.00
IBIO cash_flow (quarterly, 2025-09-30) — Change In Receivables: -65000.00
IBIO cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -529000.00
IBIO cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: -65000.00
IBIO cash_flow (quarterly, 2025-09-30) — Changes In Cash: 19547000.00
IBIO balance_sheet (quarterly, 2025-09-30) — Common Stock: 20000.00
IBIO balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 56039000.00
IBIO cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: 219000.00
IBIO balance_sheet (quarterly, 2025-09-30) — Construction In Progress: 138000.00
IBIO balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 850000.00
IBIO balance_sheet (quarterly, 2025-09-30) — Current Assets: 50772000.00
IBIO balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 504000.00
IBIO balance_sheet (quarterly, 2025-09-30) — Current Debt: 706000.00
IBIO balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 1210000.00
IBIO balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 1150000.00
IBIO balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 1150000.00
IBIO balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 6048000.00
IBIO cash_flow (quarterly, 2025-09-30) — Depreciation: 284000.00
IBIO cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 289000.00
IBIO cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 289000.00
IBIO income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 52981000.00
IBIO income_statement (quarterly, 2025-09-30) — Diluted EPS: -0.11
IBIO income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -5720000.00
IBIO income_statement (quarterly, 2025-09-30) — EBIT: -5684000.00
IBIO income_statement (quarterly, 2025-09-30) — EBITDA: -5395000.00
IBIO cash_flow (quarterly, 2025-09-30) — End Cash Position: 28339000.00
IBIO cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 46705000.00
IBIO cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -5697000.00
IBIO balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -15000.00
IBIO income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 2501000.00
IBIO balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 6843000.00
IBIO balance_sheet (quarterly, 2025-09-30) — Gross PPE: 6847000.00
IBIO income_statement (quarterly, 2025-09-30) — Interest Expense: 36000.00
IBIO income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 36000.00
IBIO income_statement (quarterly, 2025-09-30) — Interest Income: 267000.00
IBIO income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 267000.00
IBIO cash_flow (quarterly, 2025-09-30) — Interest Paid Supplemental Data: 36000.00
IBIO cash_flow (quarterly, 2025-09-30) — Interest Received Cfi: 0.00
IBIO balance_sheet (quarterly, 2025-09-30) — Invested Capital: 56745000.00
IBIO cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -21493000.00
IBIO cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 219000.00
IBIO balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 2068000.00
IBIO balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 2068000.00
IBIO cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -160000.00
IBIO balance_sheet (quarterly, 2025-09-30) — Machinery Furniture Equipment: 3995000.00
IBIO cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 219000.00
IBIO income_statement (quarterly, 2025-09-30) — Net Income: -5720000.00
IBIO income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -5720000.00
IBIO income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -5720000.00
IBIO income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -5720000.00
IBIO income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -5720000.00
IBIO cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -5720000.00
IBIO income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -5720000.00
IBIO income_statement (quarterly, 2025-09-30) — Net Interest Income: 231000.00
IBIO cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: -21461000.00
IBIO cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: -160000.00
IBIO cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: -160000.00
IBIO income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: 231000.00
IBIO cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -3360000.00
IBIO balance_sheet (quarterly, 2025-09-30) — Net PPE: 5168000.00
IBIO cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -32000.00
IBIO balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 49196000.00
IBIO balance_sheet (quarterly, 2025-09-30) — Non Current Note Receivables: 1118000.00
IBIO balance_sheet (quarterly, 2025-09-30) — Non Current Prepaid Assets: 26000.00
IBIO income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -5395000.00
IBIO income_statement (quarterly, 2025-09-30) — Normalized Income: -5720000.00
IBIO cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -5665000.00
IBIO income_statement (quarterly, 2025-09-30) — Operating Income: -5951000.00
IBIO income_statement (quarterly, 2025-09-30) — Operating Revenue: 100000.00
IBIO balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 20254599.00
IBIO balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 1140000.00
IBIO balance_sheet (quarterly, 2025-09-30) — Other Current Borrowings: 706000.00
IBIO balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: -15000.00
IBIO income_statement (quarterly, 2025-09-30) — Other Gand A: 2501000.00
IBIO balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 6843000.00
IBIO cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: -19000.00
IBIO balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 228000.00
IBIO balance_sheet (quarterly, 2025-09-30) — Other Payable: 16000.00
IBIO balance_sheet (quarterly, 2025-09-30) — Other Properties: 2019000.00
IBIO balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 21456000.00
IBIO balance_sheet (quarterly, 2025-09-30) — Payables: 2838000.00
IBIO balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 3688000.00
IBIO balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 0.00
IBIO income_statement (quarterly, 2025-09-30) — Pretax Income: -5720000.00
IBIO cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 50006000.00
IBIO balance_sheet (quarterly, 2025-09-30) — Properties: 0.00
IBIO cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -21461000.00
IBIO cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -32000.00
IBIO balance_sheet (quarterly, 2025-09-30) — Receivables: 65000.00
IBIO income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 289000.00
IBIO cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -160000.00
IBIO income_statement (quarterly, 2025-09-30) — Research And Development: 3550000.00
IBIO balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -337944000.00
IBIO income_statement (quarterly, 2025-09-30) — Selling General And Administration: 2501000.00
IBIO balance_sheet (quarterly, 2025-09-30) — Share Issued: 20254599.00
IBIO cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 323000.00
IBIO balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 56039000.00
IBIO balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 49196000.00
IBIO income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
IBIO income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.00
IBIO balance_sheet (quarterly, 2025-09-30) — Total Assets: 64155000.00
IBIO balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 56039000.00
IBIO balance_sheet (quarterly, 2025-09-30) — Total Debt: 3278000.00
IBIO balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 56039000.00
IBIO income_statement (quarterly, 2025-09-30) — Total Expenses: 6051000.00
IBIO balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 8116000.00
IBIO balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 13383000.00
IBIO balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 2068000.00
IBIO income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -5951000.00
IBIO balance_sheet (quarterly, 2025-09-30) — Working Capital: 44724000.00
IBIO income_statement (quarterly, 2025-12-31) — +Operating Expense: 9445000.00
IBIO income_statement (quarterly, 2025-12-31) — +Total Revenue: 0.00
IBIO balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 2654000.00
IBIO balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 0.00
IBIO balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -1759000.00
IBIO balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 403457000.00
IBIO balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -65000.00
IBIO cash_flow (quarterly, 2025-12-31) — Amortization Cash Flow: 5000.00
IBIO cash_flow (quarterly, 2025-12-31) — Amortization Of Intangibles: 5000.00
IBIO cash_flow (quarterly, 2025-12-31) — Amortization Of Securities: -79000.00
IBIO income_statement (quarterly, 2025-12-31) — Basic Average Shares: 99133000.00
IBIO income_statement (quarterly, 2025-12-31) — Basic EPS: -0.09
IBIO cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 28339000.00
IBIO balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 695000.00
IBIO cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -516000.00
IBIO balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 2450000.00
IBIO balance_sheet (quarterly, 2025-12-31) — Capital Stock: 30000.00
IBIO balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 28672000.00
IBIO balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 52698000.00
IBIO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 8785000.00
IBIO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -2983000.00
IBIO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: -5241000.00
IBIO cash_flow (quarterly, 2025-12-31) — Change In Account Payable: -29000.00
IBIO cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: 567000.00
IBIO cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: -122000.00
IBIO cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: 0.00
IBIO cash_flow (quarterly, 2025-12-31) — Change In Payable: -29000.00
IBIO cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 538000.00
IBIO cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: 376000.00
IBIO cash_flow (quarterly, 2025-12-31) — Change In Receivables: 0.00
IBIO cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 792000.00
IBIO cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: 0.00
IBIO cash_flow (quarterly, 2025-12-31) — Changes In Cash: 561000.00
IBIO balance_sheet (quarterly, 2025-12-31) — Common Stock: 30000.00
IBIO balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 56560000.00
IBIO cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 0.00
IBIO balance_sheet (quarterly, 2025-12-31) — Construction In Progress: 30000.00
IBIO balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 1579000.00
IBIO balance_sheet (quarterly, 2025-12-31) — Current Assets: 53368000.00
IBIO balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 518000.00
IBIO balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 518000.00
IBIO balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 1150000.00
IBIO balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 1150000.00
IBIO balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 5901000.00
IBIO cash_flow (quarterly, 2025-12-31) — Depreciation: 236000.00
IBIO cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 241000.00
IBIO cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 241000.00
IBIO income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 99133000.00
IBIO income_statement (quarterly, 2025-12-31) — Diluted EPS: -0.09
IBIO income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -8993000.00
IBIO income_statement (quarterly, 2025-12-31) — EBIT: -8952000.00
IBIO income_statement (quarterly, 2025-12-31) — EBITDA: -8711000.00
IBIO cash_flow (quarterly, 2025-12-31) — End Cash Position: 28900000.00
IBIO cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 8785000.00
IBIO cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -5757000.00
IBIO balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 10000.00
IBIO income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 5165000.00
IBIO balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 4338000.00
IBIO balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 65000.00
IBIO balance_sheet (quarterly, 2025-12-31) — Gross PPE: 7070000.00
IBIO income_statement (quarterly, 2025-12-31) — Interest Expense: 41000.00
IBIO income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 41000.00
IBIO income_statement (quarterly, 2025-12-31) — Interest Income: 493000.00
IBIO income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 493000.00
IBIO cash_flow (quarterly, 2025-12-31) — Interest Paid Supplemental Data: 36000.00
IBIO cash_flow (quarterly, 2025-12-31) — Interest Received Cfi: 0.00
IBIO balance_sheet (quarterly, 2025-12-31) — Invested Capital: 56560000.00
IBIO cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -2983000.00
IBIO cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 0.00
IBIO balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 1932000.00
IBIO balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 1932000.00
IBIO cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -614000.00
IBIO balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 4481000.00
IBIO cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 0.00
IBIO income_statement (quarterly, 2025-12-31) — Net Income: -8993000.00
IBIO income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -8993000.00
IBIO income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -8993000.00
IBIO income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -8993000.00
IBIO income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -8993000.00
IBIO cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -8993000.00
IBIO income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -8993000.00
IBIO income_statement (quarterly, 2025-12-31) — Net Interest Income: 452000.00
IBIO cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: -2467000.00
IBIO cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -614000.00
IBIO cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -614000.00
IBIO income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: 452000.00
IBIO cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -194000.00
IBIO balance_sheet (quarterly, 2025-12-31) — Net PPE: 5311000.00
IBIO cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -516000.00
IBIO balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 52222000.00
IBIO balance_sheet (quarterly, 2025-12-31) — Non Current Note Receivables: 1138000.00
IBIO balance_sheet (quarterly, 2025-12-31) — Non Current Prepaid Assets: 10000.00
IBIO income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -8711000.00
IBIO income_statement (quarterly, 2025-12-31) — Normalized Income: -8993000.00
IBIO cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: -5241000.00
IBIO income_statement (quarterly, 2025-12-31) — Operating Income: -9445000.00
IBIO income_statement (quarterly, 2025-12-31) — Operating Revenue: 0.00
IBIO balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 30053070.00
IBIO balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 670000.00
IBIO balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: 10000.00
IBIO income_statement (quarterly, 2025-12-31) — Other Gand A: 5165000.00
IBIO balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 4338000.00
IBIO cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: -20000.00
IBIO balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 228000.00
IBIO balance_sheet (quarterly, 2025-12-31) — Other Properties: 1864000.00
IBIO balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 24026000.00
IBIO balance_sheet (quarterly, 2025-12-31) — Payables: 2654000.00
IBIO balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 4233000.00
IBIO balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 0.00
IBIO income_statement (quarterly, 2025-12-31) — Pretax Income: -8993000.00
IBIO cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 9593000.00
IBIO balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
IBIO cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: -2467000.00
IBIO cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -516000.00
IBIO balance_sheet (quarterly, 2025-12-31) — Receivables: 0.00
IBIO income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 241000.00
IBIO cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -614000.00
IBIO income_statement (quarterly, 2025-12-31) — Research And Development: 4280000.00
IBIO balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -346937000.00
IBIO income_statement (quarterly, 2025-12-31) — Selling General And Administration: 5165000.00
IBIO balance_sheet (quarterly, 2025-12-31) — Share Issued: 30053070.00
IBIO cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 253000.00
IBIO balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 56560000.00
IBIO balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 52222000.00
IBIO income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
IBIO income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.00
IBIO balance_sheet (quarterly, 2025-12-31) — Total Assets: 64393000.00
IBIO balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 56560000.00
IBIO balance_sheet (quarterly, 2025-12-31) — Total Debt: 2450000.00
IBIO balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 56560000.00
IBIO income_statement (quarterly, 2025-12-31) — Total Expenses: 9445000.00
IBIO balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 7833000.00
IBIO balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 11025000.00
IBIO balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 1932000.00
IBIO income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: -9445000.00
IBIO balance_sheet (quarterly, 2025-12-31) — Working Capital: 47467000.00
IBIO income_statement (quarterly, 2026-03-31) — +Operating Expense: 8365000.00
IBIO income_statement (quarterly, 2026-03-31) — +Total Revenue: 0.00
IBIO balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 3035000.00
IBIO balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 0.00
IBIO balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -1907000.00
IBIO balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 432190000.00
IBIO balance_sheet (quarterly, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -65000.00
IBIO cash_flow (quarterly, 2026-03-31) — Amortization Cash Flow: 5000.00
IBIO cash_flow (quarterly, 2026-03-31) — Amortization Of Intangibles: 5000.00
IBIO cash_flow (quarterly, 2026-03-31) — Amortization Of Securities: -71000.00
IBIO cash_flow (quarterly, 2026-03-31) — Asset Impairment Charge: 2503000.00
IBIO income_statement (quarterly, 2026-03-31) — Basic Average Shares: 119600000.00
IBIO income_statement (quarterly, 2026-03-31) — Basic EPS: -0.06
IBIO cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 28900000.00
IBIO balance_sheet (quarterly, 2026-03-31) — Buildings And Improvements: 695000.00
IBIO cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -11000.00
IBIO balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 2325000.00
IBIO balance_sheet (quarterly, 2026-03-31) — Capital Stock: 35000.00
IBIO balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 47631000.00
IBIO balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 74797000.00
IBIO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 28154000.00
IBIO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -3111000.00
IBIO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -6084000.00
IBIO cash_flow (quarterly, 2026-03-31) — Change In Account Payable: 380000.00
IBIO cash_flow (quarterly, 2026-03-31) — Change In Accrued Expense: 415000.00
IBIO cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: -124000.00
IBIO cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: 0.00
IBIO cash_flow (quarterly, 2026-03-31) — Change In Payable: 380000.00
IBIO cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: 795000.00
IBIO cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: -2064000.00
IBIO cash_flow (quarterly, 2026-03-31) — Change In Receivables: 0.00
IBIO cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -1393000.00
IBIO cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: 0.00
IBIO cash_flow (quarterly, 2026-03-31) — Changes In Cash: 18959000.00
IBIO balance_sheet (quarterly, 2026-03-31) — Common Stock: 35000.00
IBIO balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 77537000.00
IBIO cash_flow (quarterly, 2026-03-31) — Common Stock Issuance: 3310000.00
IBIO balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 13000.00
IBIO balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 1787000.00
IBIO balance_sheet (quarterly, 2026-03-31) — Current Assets: 77251000.00
IBIO balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 532000.00
IBIO balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 532000.00
IBIO balance_sheet (quarterly, 2026-03-31) — Current Deferred Liabilities: 1150000.00
IBIO balance_sheet (quarterly, 2026-03-31) — Current Deferred Revenue: 1150000.00
IBIO balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 6504000.00
IBIO cash_flow (quarterly, 2026-03-31) — Depreciation: 245000.00
IBIO cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 250000.00
IBIO cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 250000.00
IBIO income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 119600000.00
IBIO income_statement (quarterly, 2026-03-31) — Diluted EPS: -0.06
IBIO income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -7730000.00
IBIO income_statement (quarterly, 2026-03-31) — EBIT: -7708000.00
IBIO income_statement (quarterly, 2026-03-31) — EBITDA: -7458000.00
IBIO cash_flow (quarterly, 2026-03-31) — End Cash Position: 47859000.00
IBIO cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 28154000.00
IBIO cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -6095000.00
IBIO balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -21000.00
IBIO income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 5111000.00
IBIO balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 1830000.00
IBIO balance_sheet (quarterly, 2026-03-31) — Gross Accounts Receivable: 65000.00
IBIO balance_sheet (quarterly, 2026-03-31) — Gross PPE: 6983000.00
IBIO income_statement (quarterly, 2026-03-31) — Interest Expense: 22000.00
IBIO income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 22000.00
IBIO income_statement (quarterly, 2026-03-31) — Interest Income: 657000.00
IBIO income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 657000.00
IBIO cash_flow (quarterly, 2026-03-31) — Interest Paid Supplemental Data: 0.00
IBIO cash_flow (quarterly, 2026-03-31) — Interest Received Cfi: 0.00
IBIO balance_sheet (quarterly, 2026-03-31) — Invested Capital: 77537000.00
IBIO cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -3111000.00
IBIO cash_flow (quarterly, 2026-03-31) — Issuance Of Capital Stock: 3310000.00
IBIO balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 1793000.00
IBIO balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 1793000.00
IBIO cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: 0.00
IBIO balance_sheet (quarterly, 2026-03-31) — Machinery Furniture Equipment: 4509000.00
IBIO cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: 3310000.00
IBIO income_statement (quarterly, 2026-03-31) — Net Income: -7730000.00
IBIO income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -7730000.00
IBIO income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -7730000.00
IBIO income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -7730000.00
IBIO income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -7730000.00
IBIO cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -7730000.00
IBIO income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -7730000.00
IBIO income_statement (quarterly, 2026-03-31) — Net Interest Income: 635000.00
IBIO cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: -3100000.00
IBIO cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: 0.00
IBIO cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: 0.00
IBIO income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: 635000.00
IBIO cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -2051000.00
IBIO balance_sheet (quarterly, 2026-03-31) — Net PPE: 5076000.00
IBIO cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -11000.00
IBIO balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 75707000.00
IBIO balance_sheet (quarterly, 2026-03-31) — Non Current Note Receivables: 1157000.00
IBIO balance_sheet (quarterly, 2026-03-31) — Non Current Prepaid Assets: 292000.00
IBIO income_statement (quarterly, 2026-03-31) — Normalized EBITDA: -7458000.00
IBIO income_statement (quarterly, 2026-03-31) — Normalized Income: -7730000.00
IBIO cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -6084000.00
IBIO income_statement (quarterly, 2026-03-31) — Operating Income: -8365000.00
IBIO income_statement (quarterly, 2026-03-31) — Operating Revenue: 0.00
IBIO balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 34543561.00
IBIO balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 2454000.00
IBIO balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -21000.00
IBIO income_statement (quarterly, 2026-03-31) — Other Gand A: 5111000.00
IBIO balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 1830000.00
IBIO cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: -20000.00
IBIO balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 228000.00
IBIO balance_sheet (quarterly, 2026-03-31) — Other Properties: 1766000.00
IBIO balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 27166000.00
IBIO balance_sheet (quarterly, 2026-03-31) — Payables: 3035000.00
IBIO balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 4822000.00
IBIO balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 0.00
IBIO income_statement (quarterly, 2026-03-31) — Pretax Income: -7730000.00
IBIO cash_flow (quarterly, 2026-03-31) — Proceeds From Stock Option Exercised: 26895000.00
IBIO balance_sheet (quarterly, 2026-03-31) — Properties: 0.00
IBIO cash_flow (quarterly, 2026-03-31) — Provisionand Write Offof Assets: 0.00
IBIO cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: -8500000.00
IBIO cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -11000.00
IBIO balance_sheet (quarterly, 2026-03-31) — Receivables: 0.00
IBIO income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 250000.00
IBIO cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: 0.00
IBIO income_statement (quarterly, 2026-03-31) — Research And Development: 3254000.00
IBIO balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -354667000.00
IBIO income_statement (quarterly, 2026-03-31) — Selling General And Administration: 5111000.00
IBIO balance_sheet (quarterly, 2026-03-31) — Share Issued: 34543561.00
IBIO cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 377000.00
IBIO balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 77537000.00
IBIO balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 75707000.00